Skip to content

TransMedics

US · TMDX #2536 by market cap Listed 2019
85.25 -8.77 -9.33%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions increased by 5 in the most recent period (2026/Q3).
  • Total institutional ownership rose 1.3 percentage points.

Ownership vs. money flow

Aligned

Institutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
103.65% +1.32pp
Institutions
451 +5
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund86.11%
Hedge Fund7.21%
Public Company6.07%
Individual/Insider3.18%
Private Company2.12%
Government Pension Fund1.15%
Insurance Company0.43%
Endowment Fund0.23%
Family Office/Trust0.19%

Top holders as of 2026-09-30

BlackRock 15.81% · 5.49M sh
FMR 14.88% · 5.17M sh
Vanguard Portfolio Management, LLC 5.25% · 1.83M sh
Vanguard Capital Management, LLC 4.31% · 1.50M sh
State Street Global Advisors 4.10% · 1.43M sh
Macquarie Investment Management Business Trust 2.62% · 910.50K sh
Geode Capital Management, LLC 2.56% · 888.69K sh
Barrow, Hanley, Mewhinney & Strauss, LLC 2.41% · 837.53K sh
UBS Asset Management 2.33% · 808.16K sh
Emerald Advisers, LLC 2.31% · 803.95K sh
Hood River Capital Management LLC 2.17% · 751.13K sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 30 buys · 19 sells

NameRoleStake
Waleed Hassanein Chief Executive Officer 1.62%
Edwin Kania Independent Director 0.88%
James Tobin Independent Chairperson 0.46%
Tamer Khayal Senior Vice President of International 0.04%
Nicholas Corcoran Senior Vice President of Supply Chain & Operations 0.04%
Thomas Gunderson Independent Director 0.04%
David Weill Independent Director 0.04%
Anil Ranganath Former Advisor 0.01%
Merilee Raines Independent Director 0.01%
Gerardo Hernandez Former Chief Financial Officer 0.01%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-08 James Tobin Independent Chairperson Open Market Disposition -4,059 $93.96–94.98
2026-10-27 Fernando Araujo Chief Financial Officer & Treasurer Other Acquisition +22,969 --
2026-10-27 Fernando Araujo Chief Financial Officer & Treasurer Other Derivative Acquisition +34,419 $66.90
2026-09-10 David Weill Independent Director Open Market Acquisition +1,336 $81.63
2026-08-16 James Tobin Independent Chairperson Other Disposition -18,000 --
2026-07-09 Waleed Hassanein Chief Executive Officer Other Acquisition +49,669 --
2026-07-09 Waleed Hassanein Chief Executive Officer Other Derivative Acquisition +112,984 $71.23
2026-07-09 Nicholas Corcoran Senior Vice President of Supply Chain & Operations Other Acquisition +11,727 --
2026-07-09 Nicholas Corcoran Senior Vice President of Supply Chain & Operations Other Derivative Acquisition +17,784 $71.23
2026-07-09 Gerardo Hernandez Former Chief Financial Officer Other Acquisition +17,246 --
2026-07-09 Gerardo Hernandez Former Chief Financial Officer Other Derivative Acquisition +26,153 $71.23
2026-06-14 Thomas Gunderson Independent Director Derivative Exercise and Sale -9,624 $2.21–75.06
2026-06-14 Thomas Gunderson Independent Director Derivative Exercise and Retained +9,661 $2.21
2026-05-19 Edwin Kania Independent Director Other Acquisition +2,922 --
2026-05-19 Merilee Raines Independent Director Other Acquisition +2,922 --
2026-05-19 James Tobin Independent Chairperson Other Acquisition +2,922 --
2026-05-19 Edward Basile Independent Director Other Acquisition +2,922 --
2026-05-19 Stephanie Lovell Independent Director Other Acquisition +2,922 --
2026-05-19 Thomas Gunderson Independent Director Other Acquisition +2,922 --
2026-05-19 David Weill Independent Director Other Acquisition +2,922 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 20:02:23 · For reference only, not investment advice and not tailored to your situation.

TransMedics discussion 0 comments

Add a comment